APA (7th ed.) Citation

Rodriguez-Otero, P., Usmani, S., Cohen, A. D., van de Donk, N. W. C. J., Leleu, X., Gállego Pérez-Larraya, J., . . . Kaufman, J. L. (2024). International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma. The lancet. Oncology, 25(5), . https://doi.org/10.1016/S1470-2045(24)00043-3

Chicago Style (17th ed.) Citation

Rodriguez-Otero, Paula, et al. "International Myeloma Working Group Immunotherapy Committee Consensus Guidelines and Recommendations for Optimal Use of T-cell-engaging Bispecific Antibodies in Multiple Myeloma." The Lancet. Oncology 25, no. 5 (2024). https://doi.org/10.1016/S1470-2045(24)00043-3.

MLA (9th ed.) Citation

Rodriguez-Otero, Paula, et al. "International Myeloma Working Group Immunotherapy Committee Consensus Guidelines and Recommendations for Optimal Use of T-cell-engaging Bispecific Antibodies in Multiple Myeloma." The Lancet. Oncology, vol. 25, no. 5, 2024, https://doi.org/10.1016/S1470-2045(24)00043-3.